Carealytix is a digital health company focused on transforming chronic care through user-centric technology, specifically targeting chronic disease management solutions built for a modern world.

They create digital products aimed at delivering the best possible personalized care for people living with chronic conditions.

Carealytix challenges and disrupts conventional care delivery by building scalable, data-driven offerings grounded in medicine and user-centric design. Their partnerships include healthcare providers, payers, researchers, and industry to achieve positive health outcomes.

The company emphasizes regulatory compliance, being certified as Software-as-medical-device according to EU-MDR, fully ISO-13485 certified, and 100% GDPR compliant for health data processing.

Their digital care platform aims to set new standards in kidney care, providing tools for patient education, health tracking, data sharing with providers, remote monitoring, and clinical trial support.

Key products include Mizu, a personal CKD (Chronic Kidney Disease) companion app with over 25,000 registered users, and Kidney+, a telecoaching hybrid care program that supports patients diagnosed with kidney disease with lifestyle coaching and expert support.

Carealytix creates value by improving clinical workflows, patient engagement, accelerating health research and innovation, leveraging data science and real-world evidence (RWE), and enabling integrated care for multiple chronic conditions.